Department of Radiation Oncology

Seizures in children and adolescents with high-grade glioma: a retrospective, monocentric analysis (2026) Stritzelberger J, Gesmann A, Delev D, Schwab S, Putz F, Metzler M, Trollmann R, Hamer H Journal article ESTRO recommendations on preoperative radiation therapy in breast cancer: current and future perspectives – Endorsed by ASTRO (2026) Zamagni A, Montero Luis A, Mjaaland I, Chirila ME, Ciervide R, Machiels M, Ratosa I, et al. Journal article Glycolytic flux sustains human Th1 identity and effector function via STAT1 glycosylation (2026) Abir AH, Benz J, Frey B, Bruns H, Krönke G, Gaipl U, Schober K, et al. Journal article Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy (2026) Filippi AR, Bar J, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido P, et al. Journal article Early local immune activation following intra-operative radiotherapy in human breast tissue (2026) Tiefenthaller A, Brix N, Hennel R, Pazos M, Kost B, von Bodungen V, Rack B, et al. Journal article Exploring Thoracic Radiotherapy in Metastatic NSCLC: A Retrospective Review in the Era of Immunotherapy and Targeted Therapies (2026) Mansoorian S, Lehmann J, Käsmann L, Gaus R, Richlitzki C, Kravutske H, Putz F, et al. Journal article Comprehensive geometry-based plan quality score for lung VMAT (2026) Brand J, Szkitsak J, Lobão R, Axer BN, Pieper L, Ott O, Haderlein M, et al. Journal article Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis (2026) Oertel M, Dabaja B, Görlich D, Thomas BR, Sim V, Johnstone P, Hashmi A, et al. Journal article Radiotherapy and DNA damage response inhibitors modestly sensitize HNSCC to NK cell killing, with ATM inhibition more effective than ATR inhibition (2026) Steinsdörfer L, Zülch L, Schäfer A, Frey B, Corradini S, Fietkau R, Gaipl U, Jost T Journal article Correction to: DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers (Strahlentherapie und Onkologie, (2026), 202, 4, (359-361), 10.1007/s00066-026-02511-6) (2026) Schnellhardt S, Böke S, Tribius S, Krause M, Haderlein M, Rühle A, Süß C, et al. Journal article, Erratum